RWJBarnabas Health - Monmouth Medical Center
RWJBarnabas Health - Monmouth Medical Center
Long Branch, New Jersey, United States7 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| sFOLFOXIRI in Advanced Gastroesophageal Cancer, (SAGE) | Digestive System Diseases, Digestive System Neoplasms, Esophageal Neoplasms, Head and Neck Neoplasms, Neoplasms by Site, digestive system disorder, digestive system neoplasm, esophageal disorder, neoplasm | Recruiting | Phase 2 | 2026-09-23 | NCT05332002 | |
| ATATcH Alternating Treatment Plans for Advanced Cancer | Head and Neck Neoplasms, Neoplasms by Site, Thoracic Neoplasms, head and neck cancer, lung cancer, lung disorder, lung neoplasm, neoplasm, respiratory system disorder, respiratory tract neoplasm | Recruiting | Phase 2 | 2026-04-30 | NCT05358548 | |
| Optimize Neoadjuvant Therapy in HER2-Positive Early-Stage Breast Cancer | HER2-positive Early-stage Breast Cancer | Recruiting | Phase 2 | 2026-04-23 | NCT07402473 | |
| Sequential TAS-OX Alternating With TAS-IRI Plus Bevacizumab for Late-Line Metastatic Colorectal Cancer | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, colonic disorder, colonic neoplasm, colorectal neoplasm, digestive system disorder, digestive system neoplasm, intestinal disorder, malignant colon neoplasm, neoplasm, rectal cancer, rectal disorder, rectal neoplasm | Recruiting | Phase 2 | 2026-03-18 | NCT05806931 | |
| Tirzepatide for Weight Loss Intervention in Early-Stage Hormone Receptor Positive/HER2 Negative Breast Cancer | Body Weight, Body Weight Changes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Weight Loss, hormone receptor-positive breast cancer | Recruiting | Phase 2 | 2026-01-21 | NCT06518837 | |
| Statins for Reduction of Cardiac Toxicity in Patients Receiving HER2 Targeted | Cardiotoxicity, Chemically-Induced Disorders, Drug-Related Side Effects and Adverse Reactions, Neoplasms by Site, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, cardiovascular disorder, heart disorder, injury, neoplasm, radiation injury, skin disorder | Recruiting | Phase 2 | 2025-11-14 | NCT05559164 | |
| TAS-102 and Oxaliplatin for the Treatment of Refractory Stage IV Colon Cancer | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, colonic disorder, colonic neoplasm, colorectal neoplasm, digestive system disorder, digestive system neoplasm, intestinal disorder, neoplasm, rectal disorder | Active, not recruiting | Phase 2 | 2024-11-18 | NCT04294264 |